The RetinaVue™ Network is designed for healthcare providers who want to improve management of patients with diabetes.
Now you can easily and accurately screen for diabetic retinopathy using a SIMPLE and EASY TO USE non-mydriatic fundus camera.
BREAKTHROUGH CAMERA TECHNOLOGY IS LOW COST AND EASY TO USE
One-third the cost of full-size fundus cameras
Touchless auto-focus and image capture support ease of use
Automatic evaluation of image helps ensure quality
Fast, non-mydriatic exam promotes patient comfort
The RetinaVue 100 Imager is designed to work exclusively with RetinaVue Network Software which enables viewing and transferring of images acquired by the RetinaVue 100 Imager. RetinaVue Network is designed for healthcare providers who want to improve management of their patients with diabetes.
Acquire non-mydriatic fundus images in minutes with the simple, automated Welch Allyn RetinaVue 100 Imager.
Encrypted images sent via secure HIPAA-compliant RetinaVue Network Software.
3. Analyse and Report
Images are available on the RetinaVue Network Portal for analysis and interpretation.
MEDICARE BENEFITS SCHEDULE – LISTING OF PHOTOGRAPHY WITH NON-MYDRIATIC RETINAL CAMERAS 12325* and 12326*
This service will enable General Practitioners to promptly screen for sight-threatening diabetic retinopathy at the point of consultation rather than referring at-risk patients to another health practitioner.
* Australian Government Department of Health.
Welch Allyn | Medical Devices & Equipment
Welch Allyn Australia services the South Pacific region including Australia, New Zealand and the Pacific Islands.